A group of scientists headed by Dr. Susanne Neschen and Prof. Dr. Martin Hrabě de Angelis from the Helmholtz Zentrum München, partner in the German Center for Diabetes Research, and drug manufacturer Sanofi Aventis, have discovered how metformin and SGLT2 inhibitors can reinforce each other when used together.
Read more